Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Embryonic stem cell-derived endothelial cells for treatment of hindlimb ischemia.

Huang NF, Niiyama H, De A, Gambhir SS, Cooke JP.

J Vis Exp. 2009 Jan 23;(23). pii: 1034. doi: 10.3791/1034.

2.

Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia.

Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, Kim HS, Kim BS, Chung HM.

Circulation. 2007 Nov 20;116(21):2409-19. Epub 2007 Nov 5.

3.

Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion.

Huang NF, Niiyama H, Peter C, De A, Natkunam Y, Fleissner F, Li Z, Rollins MD, Wu JC, Gambhir SS, Cooke JP.

Arterioscler Thromb Vasc Biol. 2010 May;30(5):984-91. doi: 10.1161/ATVBAHA.110.202796. Epub 2010 Feb 18.

4.

Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes.

Lee S, Valmikinathan CM, Byun J, Kim S, Lee G, Mokarram N, Pai SB, Um E, Bellamkonda RV, Yoon YS.

Biomaterials. 2015 Sep;63:158-67. doi: 10.1016/j.biomaterials.2015.06.009. Epub 2015 Jun 11.

5.

Murine model of hindlimb ischemia.

Niiyama H, Huang NF, Rollins MD, Cooke JP.

J Vis Exp. 2009 Jan 21;(23). pii: 1035. doi: 10.3791/1035.

6.

Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells.

Yamahara K, Sone M, Itoh H, Yamashita JK, Yurugi-Kobayashi T, Homma K, Chao TH, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Fukunaga Y, Tamura N, Nakao K.

PLoS One. 2008 Feb 27;3(2):e1666. doi: 10.1371/journal.pone.0001666. Erratum in: PLoS ONE. 2009;4(1). doi: 10.1371/annotation/7f0f9ad9-d300-4228-a7ec-65d906b08d2d.

7.

Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease.

Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP, Wu JC.

Circulation. 2007 Sep 11;116(11 Suppl):I46-54.

8.

Therapeutic efficacy of human embryonic stem cell-derived endothelial cells in humanized mouse models harboring a human immune system.

Yang HM, Moon SH, Choi YS, Park SJ, Lee YS, Lee HJ, Kim SJ, Chung HM.

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2839-49. doi: 10.1161/ATVBAHA.113.302462. Epub 2013 Oct 3.

9.

Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration.

Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao TH, Sawada N, Fukunaga Y, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa S, Nakao K.

Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2127-34. Epub 2007 Sep 13.

10.

Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation.

Cheung C, Sinha S.

J Mol Cell Cardiol. 2011 Nov;51(5):651-64. doi: 10.1016/j.yjmcc.2011.07.014. Epub 2011 Jul 24. Review.

PMID:
21816157
11.

Reversal of endothelial progenitor cell dysfunction in patients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells.

Ho JC, Lai WH, Li MF, Au KW, Yip MC, Wong NL, Ng ES, Lam FF, Siu CW, Tse HF.

Diabetes Metab Res Rev. 2012 Jul;28(5):462-73. doi: 10.1002/dmrr.2304. Epub 2012 Apr 10.

PMID:
22492468
12.

A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation.

Moon SH, Kim JS, Park SJ, Lee HJ, Do JT, Chung HM.

Biomaterials. 2011 Sep;32(27):6445-55. doi: 10.1016/j.biomaterials.2011.05.026. Epub 2011 Jun 11.

PMID:
21658762
13.

Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival.

Ma M, Ding S, Lundqvist A, San H, Fang F, Konoplyannikov M, Berry C, Beltran LE, Chen G, Kovacic JC, Boehm M.

Stem Cells. 2010 Sep;28(9):1465-75. doi: 10.1002/stem.475.

14.

Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.

Rufaihah AJ, Huang NF, Jamé S, Lee JC, Nguyen HN, Byers B, De A, Okogbaa J, Rollins M, Reijo-Pera R, Gambhir SS, Cooke JP.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):e72-9. doi: 10.1161/ATVBAHA.111.230938.

15.

Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo.

Kane NM, Meloni M, Spencer HL, Craig MA, Strehl R, Milligan G, Houslay MD, Mountford JC, Emanueli C, Baker AH.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1389-97. doi: 10.1161/ATVBAHA.110.204800. Epub 2010 Apr 29.

16.

Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.

Smadja DM, d'Audigier C, Bièche I, Evrard S, Mauge L, Dias JV, Labreuche J, Laurendeau I, Marsac B, Dizier B, Wagner-Ballon O, Boisson-Vidal C, Morandi V, Duong-Van-Huyen JP, Bruneval P, Dignat-George F, Emmerich J, Gaussem P.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):551-9. doi: 10.1161/ATVBAHA.110.220624. Epub 2010 Dec 9.

17.

A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling.

Xiong Q, Hill KL, Li Q, Suntharalingam P, Mansoor A, Wang X, Jameel MN, Zhang P, Swingen C, Kaufman DS, Zhang J.

Stem Cells. 2011 Feb;29(2):367-75. doi: 10.1002/stem.580.

18.

Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.

Park TS, Bhutto I, Zimmerlin L, Huo JS, Nagaria P, Miller D, Rufaihah AJ, Talbot C, Aguilar J, Grebe R, Merges C, Reijo-Pera R, Feldman RA, Rassool F, Cooke J, Lutty G, Zambidis ET.

Circulation. 2014 Jan 21;129(3):359-72. doi: 10.1161/CIRCULATIONAHA.113.003000. Epub 2013 Oct 25.

19.

The efficacy of extraembryonic stem cells in improving blood flow within animal models of lower limb ischaemia.

Mohamed Omer S, Krishna SM, Li J, Moxon JV, Nsengiyumva V, Golledge J.

Heart. 2016 Jan;102(1):69-74. doi: 10.1136/heartjnl-2015-308322. Epub 2015 Nov 16. Review.

PMID:
26573094
20.

Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.

Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, Matsumoto T, Kangawa K, Kitamura S.

Cardiovasc Res. 2005 Jun 1;66(3):543-51. Epub 2005 Mar 2.

PMID:
15914119

Supplemental Content

Support Center